Literature DB >> 20463244

Histoplasmosis.

Kenneth S Knox1, Chadi A Hage.   

Abstract

Histoplasmosis is the most prevalent endemic fungal infection in North America. The clinical spectrum ranges from asymptomatic, self-limited illness to a life-threatening progressive disseminated disease. Chronic manifestations of healed infection can also be problematic. Clinical presentation depends on the infectious load, underlying immune status, and lung function. The preferred diagnostic methods and treatment options vary with clinical scenario and severity of illness. New diagnostic tools and treatment options are now available in clinical practice. We present an overview of this important endemic mycosis with emphasis on diagnosis and treatment recommendations for the different clinical syndromes of histoplasmosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20463244     DOI: 10.1513/pats.200907-069AL

Source DB:  PubMed          Journal:  Proc Am Thorac Soc        ISSN: 1546-3222


  26 in total

1.  Histoplasmosis infections worldwide: thinking outside of the Ohio River valley.

Authors:  Nathan C Bahr; Spinello Antinori; L Joseph Wheat; George A Sarosi
Journal:  Curr Trop Med Rep       Date:  2015-06-01

Review 2.  Rheumatologic manifestations of histoplasmosis: a review.

Authors:  Travis C Sizemore
Journal:  Rheumatol Int       Date:  2013-07-09       Impact factor: 2.631

3.  Calcified granulomatous disease: occupational associations and lack of familial aggregation.

Authors:  Robert M Reed; Anthony Amoroso; Salman Hashmi; Seth Kligerman; Alan R Shuldiner; Braxton D Mitchell; Giora Netzer
Journal:  Lung       Date:  2014-07-20       Impact factor: 2.584

4.  Disseminated histoplasmosis in a patient with aplastic anemia.

Authors:  Sanjeev Kumar Sharma; Sunil Gupta; Prashant Durgapal; Anjan Mukherjee; Tulika Seth; Pravas Mishra; Manoranjan Mahapatra; Immaculata Xess; Ruma Ray; Sanjay Sharma
Journal:  Indian J Hematol Blood Transfus       Date:  2012-10-09       Impact factor: 0.900

5.  Clinical and Laboratory Profile of Persons Living with Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome and Histoplasmosis from a Colombian Hospital.

Authors:  Diego H Caceres; Angela M Tobón; Angela Ahlquist Cleveland; Christina M Scheel; Dedsy Y Berbesi; Jesús Ochoa; Angela Restrepo; Mary E Brandt; Tom Chiller; Beatriz L Gómez
Journal:  Am J Trop Med Hyg       Date:  2016-08-01       Impact factor: 2.345

6.  Detection of Histoplasma capsulatum in Organic Fertilizers by Hc100 Nested Polymerase Chain Reaction and Its Correlation with the Physicochemical and Microbiological Characteristics of the Samples.

Authors:  Luisa F Gómez; Isaura P Torres; María Del Pilar Jiménez-A; Juan Gmo McEwen; Catalina de Bedout; Carlos A Peláez; José M Acevedo; María L Taylor; Myrtha Arango
Journal:  Am J Trop Med Hyg       Date:  2018-03-08       Impact factor: 2.345

Review 7.  A review of the pathology and treatment of canine respiratory infections.

Authors:  Miranda D Vieson; Pablo Piñeyro; Tanya LeRoith
Journal:  Vet Med (Auckl)       Date:  2012-06-26

8.  Implementation of a Training Course Increased the Diagnosis of Histoplasmosis in Colombia.

Authors:  Diego H Caceres; Alejandra Zuluaga; Karen Arango-Bustamante; Catalina de Bedout; Ángela Maria Tobón; Ángela Restrepo; Beatriz L Gómez; Luz Elena Cano; Ángel González
Journal:  Am J Trop Med Hyg       Date:  2015-06-29       Impact factor: 2.345

9.  Cutaneous ulcer in an immunosuppressed patient with adult onset Still's disease: primary cutaneous histoplasmosis?

Authors:  Michelle Larissa Zini Lise; Ronaldo Nunes Godinho; Flávia Moojen Brollo; Henrique Luiz Staub
Journal:  An Bras Dermatol       Date:  2014 May-Jun       Impact factor: 1.896

10.  Accuracy of a Novel Histoplasmosis Enzyme Immunoassay to Evaluate Suspicious Lung Nodules.

Authors:  Stephen A Deppen; Pierre P Massion; Jeffrey Blume; Ronald C Walker; Sanja Antic; Heidi Chen; Michele M Durkin; L Joseph Wheat; Eric L Grogan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-10-19       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.